| Originator: |
|
MHRA Medical Device Alerts
|
|
|
|
- Care Trusts
- Mental Health Trusts
- Specialists Trusts
- NHS Regional Offices
- Learning Disabilities Trusts
- Mental Health & Social Care Trusts
- Ambulance Trusts
- Mental Health & Learning Disabilities Trusts
- Acute Trusts
- Community Trusts
|
|
|
- Other contacts
- Independent Healthcare Providers (registered with CAS)
- Clinical Commissioning Groups
- Special Health Authorities
|
| Title: |
|
Nellix Endovascular Aneurysm Sealing (EVAS) System - Device recall and enhanced patient surveillance
|
| Broadcast content: |
|
Endologix has stopped selling the Nellix EVAS device and is recalling unused stock. MHRA recommends enhanced patient surveillance due to a high risk of graft failure beyond two years after implantation.
|
| Additional information: |
|
NHS England Regional offices: do not cascade to primary care.
|
| Action underway deadline: |
|
01-Feb-2019
|
| Action complete deadline: |
|
15-Feb-2019
|